Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/01/2003US20030084023 Graphical viewer for biomolecular sequence data
05/01/2003US20030084013 Encoding of data and extraneous information into synthetic gene sequences and the retrieval of same
05/01/2003US20030084012 Method for encoding the volumetric information of a virtual object and the retrieval of same
05/01/2003US20030083487 Progestogen receptor polypeptides, transgenic cells in which genes encoding said polypeptides are introduced and method for detecting disruptors for progestogens by using said transgenic cells
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083485 Nucleotide sequences coding polypeptide for use the treament of cardiovascular disorders
05/01/2003US20030083484 Antisense modulation of short heterodimer partner-1 expression
05/01/2003US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer
05/01/2003US20030083480 Novel glyphosate N-acetyl transferase (GAT) genes
05/01/2003US20030083477 Three component chimeric antisense oligonucleotides
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083470 Polypeptide for use in controlling gene transcription and treating cancer
05/01/2003US20030083468 Polypeptide for use in the treatment of inflammation and liver disorders
05/01/2003US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083465 Protein for use in treatment and prevention of angiogenesis
05/01/2003US20030083464 Novel peptides comprising repetitive units of amino acids and DNA sequences encoding the same
05/01/2003US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083339 Using antagonists of the Angiotensin II type 2 receptor (AT2 receptor) for example candesartan cilexetil; combination treatment with an ACE inhibitor (angiotensin converting enzyme=ACE); drug screening assays
05/01/2003US20030083303 A replicated and packaged vector construct inside a virion particle in the helper cell, able expressing a foreign gene in a mammalian cell; use in transfection
05/01/2003US20030083302 An oligonucleotides are specifically hybridizable with targeted nucleic acids to inhibit the gene expression of DNA helicases
05/01/2003US20030083300 Antisense modulation of cellular inhibitor of Apoptosis-2 expression
05/01/2003US20030083299 Non-invasive delivery of polypeptides through the blood-brain barrier
05/01/2003US20030083296 Antisense modulation of caspase 8 expression
05/01/2003US20030083295 An oligonucleotides are hybridizable with nucleic acids to inhibit the gene expression of enzyme
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083293 Drug delivery of the chromosomes comprising a heterologous DNA to selected cells and tissues; transfection, production of heterologous proteins, gene therapy, generating non-human transgenic animals
05/01/2003US20030083292 Inhibitors of DNA methyltransferase isoforms
05/01/2003US20030083290 Vector system
05/01/2003US20030083289 Herpesvirus vectors and their uses
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083285 Oligonucleotides; gene therapy; prophylaxis; genetic engineering
05/01/2003US20030083284 Antisense modulation of p70 S6 kinase expression
05/01/2003US20030083283 Antisense modulation of CoREST expression
05/01/2003US20030083282 Antisense modulation of stearoyl-CoA desaturase expression
05/01/2003US20030083281 Antisense modulation of PKA regulatory subunit RII beta expression
05/01/2003US20030083280 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
05/01/2003US20030083279 Antisense modulation of glioma-associated oncogene-3 expression
05/01/2003US20030083278 Antisense modulation of CD40 ligand expression
05/01/2003US20030083276 Uses of DNA-PK
05/01/2003US20030083275 Antisense oligodeoxynucleotides regulating expression of tnf alpha
05/01/2003US20030083274 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
05/01/2003US20030083273 Antisense oligomers
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083258 Modulation of leukocyte-endothelial interactions following ischemia
05/01/2003US20030083257 Spliceable nucleotide sequence inserted into the wild-type factor viii cDNA at the original position of an intron of the genomic factor viii DNA; gene therapy; treatment of hemophilia
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083253 Polynucleotide encoding autoantigens associated with endometriosis
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030083234 Anti-angiogenesis methods, compositions and uses therefor
05/01/2003US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy
05/01/2003US20030082815 Nucleotide sequences coding polypeptide for use in the biosynthesis of riboflavin
05/01/2003US20030082814 Secretion of T cell receptor fragments from recombinant escherichia coli cells
05/01/2003US20030082813 Promotion of somatic embryogenesis in plants by wuschel gene expression
05/01/2003US20030082811 Preparing preferential viral vectors; provide packaging cell, transfect with nucleotide sequences coding viral vector, culture transfected cells, recover packaged vector
05/01/2003US20030082809 Universal light-switchable gene promoter system
05/01/2003US20030082805 Methods for use of mpl ligands with primitive human stem cells
05/01/2003US20030082800 Expression vector for use in the generation of single stranded nucleotide sequences
05/01/2003US20030082799 Low-temperature inducible expression vector
05/01/2003US20030082790 Isolated enzymatic polypetide for use as tool in genetic engineering
05/01/2003US20030082789 Packaging plasmid for use as gene transfer tool in genetic engineering
05/01/2003US20030082788 Recombinant infectious laryngotracheitis virus and uses thereof
05/01/2003US20030082786 PEG-modified uricase
05/01/2003US20030082780 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases
05/01/2003US20030082779 BGL3 beta-glucosidase and nucleic acids encoding the same
05/01/2003US20030082778 Regulation of promoter activity in cells
05/01/2003US20030082776 Nucleotide sequences coding enzymatic polypeptide for use in therapeutic drug design
05/01/2003US20030082772 Amine oxidase for use in the treatment of nervous system disorders
05/01/2003US20030082770 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer
05/01/2003US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
05/01/2003US20030082768 Nucleotide sequences coding polypeptide for use in the generation preferential biopolymers
05/01/2003US20030082766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082764 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082762 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082761 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082760 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082759 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082753 Generation of expression vector for use as gene transfer tool; prepare nutrient broth, inoculate with yeast, propagate, transform yeast, express vector, recover encapsidated particle
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082746 Process for producing transglutaminase
05/01/2003US20030082743 Polypeptide sequences of human EDG-1c
05/01/2003US20030082742 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
05/01/2003US20030082741 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082738 Nucleotide sequences coding polypeptide for use in the treatment and prevention of pain and cardiovascular disorders
05/01/2003US20030082737 Nucleotide sequences coding polypeptide for use in the eating disorders
05/01/2003US20030082736 Nucleotide sequences coding polypeptide for use in the treatment of cachexia, sepsis, arthritis, diabetes, multiple sclerosis, fibrosis, cerebral, allograft and xenograft disorders
05/01/2003US20030082735 Selection of cells expressing heteromeric polypeptides
05/01/2003US20030082727 Modulatory proteins of human CNS receptors
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082724 Nucleotide seqeuences for se as tool in plant genetic engineering
05/01/2003US20030082723 Use of mutated recognition sequences for multiple consecutive recombinase-mediated recombinations in a genetic system
05/01/2003US20030082722 Method for amplifying expression from a cell specific promoter
05/01/2003US20030082721 Transgenic animals expressing androgen receptor complex-associated protein
05/01/2003US20030082719 Generation of preferential lymphocyte receptor; generate nucleotide sequence coding receptor protein, transform cell, express nucleotide sequences, recover receptor protein, evaluate binding activity
1 ... 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 ... 4023